s-adenosylmethionine has been researched along with Adverse Drug Event in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aithal, GP; Alvarez-Alvarez, I; Andrade, RJ; Arikan, C; Atallah, E; Lucena, MI; Medina-Caliz, I; Niu, H | 1 |
| Antonelli-Incalzi, R; Galvano, A; Russo, A; Santini, D; Terenzio, A; Tonini, G; Vespasiani-Gentilucci, U; Vincenzi, B; Vorini, F | 1 |
| Beger, RD; Chen, M; Dragan, Y; Holland, RD; Schnackenberg, LK; Sun, J; Tong, W; Welsh, W | 1 |
| Howland, RH | 1 |
2 review(s) available for s-adenosylmethionine and Adverse Drug Event
| Article | Year |
|---|---|
Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review.
Topics: Acetaminophen; Acetylcysteine; Adolescent; Adrenal Cortex Hormones; Adult; Carnitine; Chemical and Drug Induced Liver Injury; Child; Drug-Related Side Effects and Adverse Reactions; Glutathione; Glycyrrhizic Acid; Humans; Infant, Newborn; Liver; Liver Failure, Acute; Retrospective Studies; S-Adenosylmethionine; Ursodeoxycholic Acid | 2022 |
The use of SAMe in chemotherapy-induced liver injury.
Topics: Animals; Antineoplastic Agents; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Humans; Neoplasms; S-Adenosylmethionine | 2018 |
2 other study(ies) available for s-adenosylmethionine and Adverse Drug Event
| Article | Year |
|---|---|
Evaluations of the trans-sulfuration pathway in multiple liver toxicity studies.
Topics: Animals; Chemical and Drug Induced Liver Injury; Comet Assay; Creatine; Drug-Related Side Effects and Adverse Reactions; Gene Expression Profiling; Glutathione; Liver; Male; Rats; Rats, Sprague-Dawley; S-Adenosylmethionine; Taurine | 2009 |
Dietary supplement drug therapies for depression.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Depressive Disorder; Dietary Supplements; Drug Approval; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Fatty Acids, Omega-3; Humans; Inositol; S-Adenosylmethionine; Self Medication; Tetrahydrofolates; Treatment Outcome; Tryptophan; United States; United States Food and Drug Administration | 2012 |